enVVeno Medical (NVNO) Long-Term Deferred Tax (2020 - 2021)
enVVeno Medical's quarterly Long-Term Deferred Tax came in at $14.5 million in Q4 2021, up 35.24% year-on-year from $10.7 million in Q4 2020, and up 35.24% quarter-over-quarter from $10.7 million in Q4 2020.
enVVeno Medical has reported Long-Term Deferred Tax for 2 years, with the latest figure at $14.5 million in Q4 2021.
- For the quarter ending Q4 2021, Long-Term Deferred Tax rose 35.24% year-over-year to $14.5 million; the trailing twelve-month figure through Dec 2021 stood at $14.5 million (up 35.24% YoY), and the FY2021 full-year result was $14.5 million, up 35.24% from the prior year.
- Long-Term Deferred Tax for Q4 2021 stood at $14.5 million, up from $10.7 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $14.5 million in Q4 2021, with the low at $10.7 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | enVVeno Medical | 6.99 Mn | 6.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 14.48 Mn |
| Dec 31, 2020 | 10.71 Mn |